Felix Sahm

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 476 publications

Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.

Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.

Journal: Nature cancer
Published: August 03, 2026

Methodological considerations in the assessment of hemizygous CDKN2A/B deletions in meningioma and IDH-mutant glioma.

Methodological considerations in the assessment of hemizygous CDKN2A/B deletions in meningioma and IDH-mutant glioma.

Journal: Neuro-oncology
Published: July 06, 2026

Neuronal precursor cell persistence in ganglioglioma is associated with extracellular matrix remodeling and immune cell infiltration.

Neuronal precursor cell persistence in ganglioglioma is associated with extracellular matrix remodeling and immune cell infiltration.

Journal: Neuro-oncology advances
Published: April 27, 2026

Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma.

Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma.

Journal: Neuropathology and applied neurobiology
Published: April 20, 2026

Multidisciplinary management of meningiomas in the era of precision oncology.

Multidisciplinary management of meningiomas in the era of precision oncology.

Journal: Nature reviews. Clinical oncology
Published: March 26, 2026

Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting.

Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting.

Journal: Brain pathology (Zurich, Switzerland)
Published: March 13, 2026

Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat.

Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat.

Journal: Science translational medicine
Published: March 04, 2026

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Journal: Acta neuropathologica
Published: February 21, 2026

Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience.

Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience.

Journal: Genome medicine
Published: February 17, 2026

Prognostic impact of radiotherapy timing in WHO grade 2 and 3 meningiomas utilizing an integrated molecular-morphologic classification.

Prognostic impact of radiotherapy timing in WHO grade 2 and 3 meningiomas utilizing an integrated molecular-morphologic classification.

Journal: Journal of neuro-oncology
Published: February 04, 2026

IDH status shapes glioma oncotopy: voxel-wise mapping of 644 adult diffuse gliomas.

IDH status shapes glioma oncotopy: voxel-wise mapping of 644 adult diffuse gliomas.

Journal: Neuroradiology
Published: January 16, 2026

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Journal: Nature communications
Published: January 09, 2026
Showing 1-12 of 476

Last Updated: 09/26/2026